Xiaojie Wu

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 7

Top Topics

Hepatitis C Virus

Top Venues

Antimicrobial agents and chemotherapy

This page only lists publications with an associated author ORCID identifier.

Publications

Size Li, Xu Zhu, Guoying Cao, Jufang Shen, Xu Zhu, Jicheng Yu, Xiaojie Wu, Jufang Wu, Haijing Yang, Nanyang Li, Yingying Hu, Jingjing Wang, Haihui Huang, Wanzhen Li
Pharmacokinetics and safety of EVER206, a novel polymyxin antimicrobial, in healthy Chinese subjects. Antimicrobial agents and chemotherapy (2024)
Yuran Cao, Xiaojie Wu, Zhiqiang Wang, Yuxian Huang, Junzhen Wu, Guoying Cao, Jicheng Yu, Jingjing Wang, Haijing Yang, Wenhong Zhang, Wanzhen Li
Single-Ascending-Dose, Food-Effect, and Multiple-Dose Study of the Safety, Tolerability, and Pharmacokinetics of the Pangenotypic Anti-Hepatitis C Virus Drug Holybuvir in Healthy Chinese Subjects. Antimicrobial agents and chemotherapy 67 (3) (2023)
Yuran Cao, Xiaojie Wu, Zhiqiang Wang, Yuxian Huang, Junzhen Wu, Guoying Cao, Jicheng Yu, Jingjing Wang, Haijing Yang, Wenhong Zhang, Wanzhen Li
Single-Ascending-Dose, Food-Effect, and Multiple-Dose Study of the Safety, Tolerability, and Pharmacokinetics of the Pangenotypic Anti-Hepatitis C Virus Drug Holybuvir in Healthy Chinese Subjects. Antimicrobial agents and chemotherapy 67 (3) (2023)
Zhiwei Huang, Xinyi Yang, Yi Jin, Jicheng Yu, Guoying Cao, Jingjing Wang, Yingying Hu, Jingyi Dai, Jufang Wu, Qiong Wei, Yan Tian, Shuyan Yu, Xu Zhu, Xiaomeng Mao, Wei Liu, Hong Liang, Shansong Zheng, Yunfei Ju, Zenghua Wang, Wanzhen Li, Xiaojie Wu
First-in-human study to evaluate the safety, tolerability, and population pharmacokinetic/pharmacodynamic target attainment analysis of FL058 alone and in combination with meropenem in healthy subjects. Antimicrobial agents and chemotherapy (2023)
Yuran Cao, Xiaojie Wu, Zhiqiang Wang, Yuxian Huang, Junzhen Wu, Guoying Cao, Jicheng Yu, Jingjing Wang, Haijing Yang, Wenhong Zhang, Wanzhen Li
Single-Ascending-Dose, Food-Effect, and Multiple-Dose Study of the Safety, Tolerability, and Pharmacokinetics of the Pangenotypic Anti-Hepatitis C Virus Drug Holybuvir in Healthy Chinese Subjects. Antimicrobial agents and chemotherapy (2023)
Yuran Cao, Xiaojie Wu, Zhiqiang Wang, Yuxian Huang, Junzhen Wu, Guoying Cao, Jicheng Yu, Jingjing Wang, Haijing Yang, Wenhong Zhang, Wanzhen Li
Single-Ascending-Dose, Food-Effect, and Multiple-Dose Study of the Safety, Tolerability, and Pharmacokinetics of the Pangenotypic Anti-Hepatitis C Virus Drug Holybuvir in Healthy Chinese Subjects. Antimicrobial agents and chemotherapy 67 (3) (2023)
Yuran Cao, Xiaojie Wu, Zhiqiang Wang, Yuxian Huang, Junzhen Wu, Guoying Cao, Jicheng Yu, Jingjing Wang, Haijing Yang, Wenhong Zhang, Wanzhen Li
Single-Ascending-Dose, Food-Effect, and Multiple-Dose Study of the Safety, Tolerability, and Pharmacokinetics of the Pangenotypic Anti-Hepatitis C Virus Drug Holybuvir in Healthy Chinese Subjects. Antimicrobial agents and chemotherapy 67 (3) (2023)